Search clinical trials for: YY1201 2ml
Total 0 results
Nothing found
Sponsors and Collaborators
- MingSight Pharmaceuticals Pty Limited
- Marilia Medicine School
- Zahra Rabbani Khah
- European Network For Smoking and Tobacco Prevention
- Jeffrey Rudolph
- The Third Hospital of Changsha
- Kawin Technology Share-holding Co., Ltd.
- Ionis Pharmaceuticals
- CTC Bio, Inc.
- New York State Health Foundation
- John Granton
- Medtronic Atrial Fibrillation Solutions
- Montreal Neurological Institute and Hospital
- Rex Bionics Plc
- Wushan County People's Hospital
- Mitchell Scheiman
- Northern California Melanoma Center
- Honda R and D Americas, Inc.
- Health Parametrics Inc.
- Jeffrey W. Clark, MD
- View Full List
Medical Conditions
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
- Low Birthweight, Extremely (999 Grams or Less)
- Nutritional Edema
- Improved Vocal Fold Status
- Pertussis Immunisation
- Heart Defect, Congenital
- Ketamine Treatment
- Suspected Neonatal Encephalopathy
- Canthal Lines
- Influenza and Other Novel Respiratory Viruses
- Pediatric Anaplastic Large Cell Lymphoma
- Radial Artery Catheterization
- Acute Necrotizing Encephalopathy
- Myeloproliferative Disease
- Periodontology
- Moderate to Severe Functional Impairments
- Fecal Elastase-1 Test
- Postmenopausal Diabetes
- Idiopathic Gastric Stasis
- View Full List
Drug Interventions
- Toripalimab plus Anlotinib
- Postoperative analgesia management
- Nimotuzumab
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Levobupivacaine, clonidine
- Rifaximin
- Bendamustine
- Levcromakalim
- AZD7798
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Ombrabulin (AVE8062)
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Pentostatin
- CKD-519
- ESK981
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- 200 µg doxorubicin-containing MNA
- Fludarabine
- Hydroxychloroquine
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Chile
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Finland
- Contract Research Organizations in Gabon
- Contract Research Organizations in Jordan
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Uzbekistan
- CRO list by country